Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer’s product outlook is brightening in 2004, with the launch of three commercially significant new molecular entity products on the horizon.